Oncolytic polio/rhinovirus recombinant (PVSRIPO) against WHO grade IV malignant glioma (MG): Experience with retreatment of survivors from the phase I trial.

Published

Conference Paper

Full Text

Duke Authors

Cited Authors

  • Desjardins, A; Gromeier, M; Herndon, JE; Randazzo, D; Threatt, S; Lipp, ES; Miller, ES; Jackman, J; Bolognesi, DP; Friedman, AH; Friedman, HS; McSherry, F; Peters, KB; Johnson, MO; Sampson, JH; Ashley, DM; Bigner, DD

Published Date

  • May 20, 2019

Published In

Volume / Issue

  • 37 / 15_suppl

Start / End Page

  • 2060 - 2060

Published By

Electronic International Standard Serial Number (EISSN)

  • 1527-7755

International Standard Serial Number (ISSN)

  • 0732-183X

Digital Object Identifier (DOI)

  • 10.1200/jco.2019.37.15_suppl.2060